BMY logo

Bristol-Myers Squibb (BMY) Accounts Receivable

Annual Accounts Receivable

$8.88 B
+$731.00 M+8.97%

December 31, 2023


Summary


Performance

BMY Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBMYbalance sheetmetrics:

Quarterly Accounts Receivable

$9.32 B
-$429.00 M-4.40%

September 30, 2024


Summary


Performance

BMY Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBMYbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

BMY Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.0%+4.9%
3 y3 years+23.0%+4.9%
5 y5 years+91.6%+4.9%

BMY Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+11.3%-4.4%+30.2%
5 y5-yearat high+37.1%-4.4%+43.9%
alltimeall timeat high+425.6%-4.4%+474.1%

Bristol-Myers Squibb Accounts Receivable History

DateAnnualQuarterly
Sep 2024
-
$9.32 B(-4.4%)
Jun 2024
-
$9.75 B(+10.4%)
Mar 2024
-
$8.83 B(-0.6%)
Dec 2023
$8.88 B(+9.0%)
$8.88 B(+5.7%)
Sep 2023
-
$8.41 B(+3.5%)
Jun 2023
-
$8.13 B(+3.5%)
Mar 2023
-
$7.85 B(-3.6%)
Dec 2022
$8.15 B(+2.2%)
$8.15 B(+1.6%)
Sep 2022
-
$8.02 B(+5.7%)
Jun 2022
-
$7.59 B(+6.0%)
Mar 2022
-
$7.16 B(-10.3%)
Dec 2021
$7.98 B(+10.5%)
$7.98 B(+1.3%)
Sep 2021
-
$7.88 B(+2.1%)
Jun 2021
-
$7.71 B(+7.3%)
Mar 2021
-
$7.19 B(-0.4%)
Dec 2020
$7.22 B(+11.5%)
$7.22 B(+6.5%)
Sep 2020
-
$6.78 B(+1.2%)
Jun 2020
-
$6.70 B(-7.0%)
Mar 2020
-
$7.20 B(+11.2%)
Dec 2019
$6.48 B(+39.7%)
$6.48 B(+51.0%)
Sep 2019
-
$4.29 B(-4.8%)
Jun 2019
-
$4.50 B(-2.0%)
Mar 2019
-
$4.59 B(-0.9%)
Dec 2018
$4.64 B(+6.6%)
$4.64 B(+0.3%)
Sep 2018
-
$4.62 B(+6.9%)
Jun 2018
-
$4.32 B(-1.2%)
Mar 2018
-
$4.37 B(+0.6%)
Dec 2017
$4.35 B(+15.2%)
$4.35 B(+0.3%)
Sep 2017
-
$4.33 B(+2.7%)
Jun 2017
-
$4.22 B(+3.3%)
Mar 2017
-
$4.08 B(+8.2%)
Dec 2016
$3.77 B(+28.0%)
$3.77 B(-1.0%)
Sep 2016
-
$3.81 B(+3.5%)
Jun 2016
-
$3.69 B(+9.6%)
Mar 2016
-
$3.36 B(+14.1%)
Dec 2015
$2.95 B(+40.4%)
$2.95 B(+8.6%)
Sep 2015
-
$2.71 B(+6.7%)
Jun 2015
-
$2.54 B(+13.0%)
Mar 2015
-
$2.25 B(+7.1%)
Dec 2014
$2.10 B(+24.3%)
$2.10 B(+15.2%)
Sep 2014
-
$1.82 B(+1.3%)
Jun 2014
-
$1.80 B(+3.3%)
Mar 2014
-
$1.74 B(+3.1%)
Dec 2013
$1.69 B
$1.69 B(-8.1%)
Sep 2013
-
$1.84 B(-0.6%)
Jun 2013
-
$1.85 B(+2.9%)
DateAnnualQuarterly
Mar 2013
-
$1.80 B(+5.3%)
Dec 2012
$1.71 B(-24.1%)
$1.71 B(-1.5%)
Sep 2012
-
$1.73 B(+6.8%)
Jun 2012
-
$1.62 B(-55.1%)
Mar 2012
-
$3.61 B(+60.6%)
Dec 2011
$2.25 B(-46.9%)
$2.25 B(+3.2%)
Sep 2011
-
$2.18 B(+3.1%)
Jun 2011
-
$2.12 B(+3.4%)
Mar 2011
-
$2.05 B(+13.4%)
Jun 2010
-
$1.80 B(-57.3%)
Sep 2008
-
$4.22 B(-5.5%)
Jun 2008
-
$4.47 B(-1.6%)
Mar 2008
-
$4.54 B(+7.1%)
Dec 2007
$4.24 B(+30.6%)
$4.24 B(+14.5%)
Sep 2007
-
$3.70 B(+2.0%)
Jun 2007
-
$3.63 B(+7.4%)
Mar 2007
-
$3.38 B(+4.1%)
Dec 2006
$3.25 B(-3.9%)
$3.25 B(+10.3%)
Sep 2006
-
$2.94 B(-11.5%)
Jun 2006
-
$3.33 B(+2.8%)
Mar 2006
-
$3.24 B(-4.2%)
Dec 2005
$3.38 B(-22.8%)
$3.38 B(+2.2%)
Sep 2005
-
$3.31 B(-0.3%)
Jun 2005
-
$3.31 B(-9.1%)
Mar 2005
-
$3.65 B(-16.6%)
Dec 2004
$4.37 B(+19.5%)
$4.37 B(+14.8%)
Sep 2004
-
$3.81 B(+8.6%)
Jun 2004
-
$3.51 B(+12.9%)
Mar 2004
-
$3.11 B(-15.1%)
Dec 2003
$3.66 B(+23.3%)
$3.66 B(+2.0%)
Sep 2003
-
$3.59 B(+11.7%)
Jun 2003
-
$3.21 B(+0.8%)
Mar 2003
-
$3.19 B(+7.4%)
Dec 2002
$2.97 B(-25.7%)
$2.97 B(-17.9%)
Sep 2002
-
$3.62 B(+4.2%)
Jun 2002
-
$3.47 B(-3.6%)
Mar 2002
-
$3.60 B(-9.8%)
Dec 2001
$3.99 B(+9.0%)
$3.99 B(+6.8%)
Sep 2001
-
$3.74 B(+5.3%)
Jun 2001
-
$3.55 B(-10.0%)
Mar 2001
-
$3.95 B(+7.8%)
Dec 2000
$3.66 B(+11.9%)
$3.66 B(-3.2%)
Sep 2000
-
$3.78 B(+15.6%)
Dec 1999
$3.27 B(+2.6%)
$3.27 B(+2.6%)
Dec 1998
$3.19 B(+7.3%)
$3.19 B(+1.9%)
Sep 1998
-
$3.13 B(+5.2%)
Dec 1997
$2.97 B
$2.97 B

FAQ

  • What is Bristol-Myers Squibb annual accounts receivable?
  • What is the all time high annual accounts receivable for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual accounts receivable year-on-year change?
  • What is Bristol-Myers Squibb quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly accounts receivable year-on-year change?

What is Bristol-Myers Squibb annual accounts receivable?

The current annual accounts receivable of BMY is $8.88 B

What is the all time high annual accounts receivable for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual accounts receivable is $8.88 B

What is Bristol-Myers Squibb annual accounts receivable year-on-year change?

Over the past year, BMY annual accounts receivable has changed by +$731.00 M (+8.97%)

What is Bristol-Myers Squibb quarterly accounts receivable?

The current quarterly accounts receivable of BMY is $9.32 B

What is the all time high quarterly accounts receivable for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly accounts receivable is $9.75 B

What is Bristol-Myers Squibb quarterly accounts receivable year-on-year change?

Over the past year, BMY quarterly accounts receivable has changed by +$435.00 M (+4.90%)